Literature DB >> 23245816

Definition, incidence, risk factors, and prevention of paralytic ileus following radical cystectomy: a systematic review.

Jorge A Ramirez1, Andrew G McIntosh, Robert Strehlow, Valerie A Lawrence, Dipen J Parekh, Robert S Svatek.   

Abstract

CONTEXT: Postoperative paralytic ileus (POI) has profound clinical consequences because it represents a substantial burden on both patients and health care resources.
OBJECTIVE: To determine the knowledge base regarding POI in the radical cystectomy (RC) population with an emphasis on preventive measures and risk factors. EVIDENCE ACQUISITION: A systematic literature search of Medline (1966 to February 2011) and a study review were conducted. Eligible studies explicitly reported the incidence of POI and/or at least two quantitative measures of gastrointestinal recovery. EVIDENCE SYNTHESIS: The search identified 727 relevant articles; 77 met eligibility criteria, comprising 13 793 patients. Of these, 21 used explicit definitions of POI, and they varied widely. Across studies, the incidence of POI ranged from 1.58% to 23.5%. Possible risk factors for POI included increasing age and body mass index. Seventeen studies reported effects of an intervention on POI: 3 randomized controlled studies, 11 observational cohort studies with concurrent comparison, and 3 observational cohort studies with nonconcurrent comparison. Gum chewing was associated with shortened times to flatus (2.4 vs 2.9 d; p<0.0001) and bowel movement (BM) (3.2 vs 3.9 d; p<0.001) in one observational cohort study (n=102); omission of a postoperative nasogastric tube (NGT) was associated with shorter time to flatus (4.21 vs 5.33 d; p=0.0001) and shorter length of stay (14.4 vs 19.1 d; p=0.001) in one observational cohort study (n=430); and the routine use of bowel preparation was associated with an increased incidence of POI (5% vs 19%) in another series (n=86). Additionally, readaptation of the dorsolateral peritoneal layer was shown to shorten times to flatus (p=0.016) and times to BM (p=0.011) in one randomized controlled study (n=200).
CONCLUSIONS: The incidence/definition of POI after RC is highly variable. An improved reporting strategy is needed to identify true incidence and risk factors, and to guide future research for both potential preventive and therapeutic interventions.
Copyright © 2012 European Association of Urology. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Cystectomy; Ileus; Review

Mesh:

Year:  2012        PMID: 23245816     DOI: 10.1016/j.eururo.2012.11.051

Source DB:  PubMed          Journal:  Eur Urol        ISSN: 0302-2838            Impact factor:   20.096


  21 in total

Review 1.  Is it necessary to insert nasogastric tube routinely after radical cystectomy with urinary diversion? A meta-analysis.

Authors:  Tao Zhao; Long Huang; Yiyang Tian; Haizhou Wang; Qiang Wei; Xiang Li
Journal:  Int J Clin Exp Med       Date:  2014-12-15

2.  90-Day complication rate in patients undergoing radical cystectomy with enhanced recovery protocol: a prospective cohort study.

Authors:  Hooman Djaladat; Behrod Katebian; Soroush T Bazargani; Gus Miranda; Jie Cai; Anne K Schuckman; Siamak Daneshmand
Journal:  World J Urol       Date:  2016-10-12       Impact factor: 4.226

3.  Redefining the implications of nasogastric tube placement following radical cystectomy in the alvimopan era.

Authors:  Vignesh T Packiam; Vijay A Agrawal; Joseph J Pariser; Andrew J Cohen; Charles U Nottingham; Shane M Pearce; Norm D Smith; Gary D Steinberg
Journal:  World J Urol       Date:  2016-07-30       Impact factor: 4.226

4.  Complications within 90 days after radical cystectomy for bladder cancer: results of a multicenter prospective study in Japan.

Authors:  Megumi Hirobe; Toshiaki Tanaka; Tetsuya Shindo; Koji Ichihara; Hiroshi Hotta; Atsushi Takahashi; Ryuichi Kato; Masahiro Yanase; Masanori Matsukawa; Naoki Itoh; Yasuharu Kunishima; Keisuke Taguchi; Hiroki Horita; Naoya Masumori
Journal:  Int J Clin Oncol       Date:  2018-02-13       Impact factor: 3.402

5.  The morbidity of laparoscopic radical cystectomy: analysis of postoperative complications in a multicenter cohort by the European Association of Urology (EAU)-Section of Uro-Technology.

Authors:  Simone Albisinni; Marco Oderda; Laurent Fossion; Virginia Varca; Jens Rassweiler; Xavier Cathelineau; Piotr Chlosta; Alexandre De la Taille; Franco Gaboardi; Thierry Piechaud; Peter Rimington; Laurent Salomon; Rafael Sanchez-Salas; Jens-Uwe Stolzenburg; Dogu Teber; Roland Van Velthoven
Journal:  World J Urol       Date:  2015-07-02       Impact factor: 4.226

Review 6.  Alvimopan for recovery of bowel function after radical cystectomy.

Authors:  Shahnaz Sultan; Bernadette Coles; Philipp Dahm
Journal:  Cochrane Database Syst Rev       Date:  2017-05-02

7.  Defining postoperative ileus and associated risk factors in patients undergoing radical cystectomy with an Enhanced Recovery After Surgery (ERAS) program.

Authors:  Connor M Forbes; Ali Cyrus Chehroudi; Miles Mannas; Andrea Bisaillon; Tracey Hong; Alan I So; Kelly Mayson; Peter C Black
Journal:  Can Urol Assoc J       Date:  2021-02       Impact factor: 1.862

Review 8.  Gastrointestinal Complications in Patients Who Undergo Radical Cystectomy with Enhanced Recovery Protocol.

Authors:  Hooman Djaladat; Siamak Daneshmand
Journal:  Curr Urol Rep       Date:  2016-07       Impact factor: 3.092

Review 9.  SIU-ICUD consultation on bladder cancer: treatment of muscle-invasive bladder cancer.

Authors:  Jeffrey J Leow; Jens Bedke; Karim Chamie; Justin W Collins; Siamak Daneshmand; Petros Grivas; Axel Heidenreich; Edward M Messing; Trevor J Royce; Alexander I Sankin; Mark P Schoenberg; William U Shipley; Arnauld Villers; Jason A Efstathiou; Joaquim Bellmunt; Arnulf Stenzl
Journal:  World J Urol       Date:  2019-01-25       Impact factor: 4.226

10.  Risk factors of postoperative ileus following laparoscopic radical cystectomy and developing a points-based risk assessment scale.

Authors:  Xiaoqiang Xue; Dong Wang; Zhigang Ji; Yi Xie
Journal:  Transl Androl Urol       Date:  2021-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.